Clinical Trial Update: Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and activity of a combination therapy (VRC07-523LS and Vorinostat) in HIV-1 infected individuals has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VRC07-523LS
• Vorinostat (vorinostat)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV-1 Infection | Phase 1 | Status: COMPLETED | Results posted: 2021-12-02